Advanced glycation end products: Possible link between metabolic syndrome and periodontal diseases

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 9-17

  Pietropaoli, Davide ^a   Monaco, A ^a   Del Pinto, R ^a   Cifone, M G ^a   Marzo, G ^a   Giannoni, M ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Advanced glycation end products; AGE; AGEs; Metabolic syndrome; Oxidative stress; Periodontal disease; ROS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; REACTIVE OXYGEN METABOLITE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; FREE RADICAL;

HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; LIPID PEROXIDATION; METABOLIC SYNDROME X; OXIDATIVE STRESS; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; ALVEOLAR BONE LOSS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GLYCOSYLATION; INFLAMMATION; PATHOGENESIS; RISK FACTOR;

EID: 84861473810     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500102     Document Type: Review

References (45)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356-9. (Pubitemid 34251969)
2. Pietropaoli D, Tatone C, D'Alessandro AM, Monaco A. Possible involvement of advanced glycation end products in periodontal diseases. Int J Immunopathol Pharmacol 2010; 23(3):683-91.
3. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress. Hormones (Athens) 2008; 7(2):123-32.
4. Lakka H-M, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288(21):2709-16. (Pubitemid 35403784)
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19):2486-97.
6. Alberti K, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366(9491):1059-62. (Pubitemid 41338752)
7. Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. Atherosclerosis 2000; 153(2):263-72. (Pubitemid 32120325)
8. Harano Y, Suzuki M, Koyama Y, et al. Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases. J Diabetes Complicat 2002; 16(1):19-23. (Pubitemid 34168495)
9. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 2009; 88(6):503-18.
10. Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005; 25(12):2587-93. (Pubitemid 43732283)
11. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signalling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52(1):1-8. (Pubitemid 36042100)
12. Odrowaz-Sypniewska G. Markers of proinflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Adv Med Sci 2007; 52:246-50.
13. Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 2001; 50(2):404-10. (Pubitemid 32127299)
14. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb Vasc Biol 2004; 24(5):816-23. (Pubitemid 38620857)
15. Soory M. Redox status in periodontal and systemic inflammatory conditions including associated neoplasias: antioxidants as adjunctive therapy? Infect Disord Drug Targets 2009; 9(4):415-27.
16. Perlstein MI, Bissada NF. Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol 1977; 43(5):707-19. (Pubitemid 8095321)
17. Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obes Rev 2011; 12(5):e381-404.
18. Pischon N, Heng N, Bernimoulin J-P, Kleber B-M, Willich SN, Pischon T. Obesity, inflammation, and periodontal disease. J Dent Res 2007; 86(5):400-9.
19. Thornalley PJ. Dicarbonyl intermediates in the maillard reaction. Ann NY Acad Sci 2005; 1043:111-7. (Pubitemid 41123896)
20. Ramasamy R, Vannucci SJ, Yan SSD, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15(7):16R-28R. (Pubitemid 41417992)
21. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001; 56:1-21.
22. Schmidt AM, Stern DM. Hyperinsulinemia and vascular dysfunction: the role of nuclear factor-kappaB, yet again. Circ Res 2000; 87(9):722-4.
23. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240(4858):1546-8.
24. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000; 275(50):39027-31. (Pubitemid 32058915)
25. Siebel AL, Fernandez AZ, El-Osta A. Glycemic memory associated epigenetic changes. Biochem Pharmacol 2010; 80(12):1853-9.
26. El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205(10):2409-17.
27. Han S-H, Kim YH, Mook-Jung I. RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 2011; 31 (2):91-7.
28. Miyata T, Ueda Y, Yoshida A, et al. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 1997; 51(3):880-7. (Pubitemid 27157977)
29. Needleman IG, Worthington HV, Giedrys-Leeper E, Tucker RJ. Guided tissue regeneration for periodontal infra-bony defects. Cochrane Database Syst Rev 2006; (2):CD001724.
30. Sheikhi M, Gustafsson A, Jarstrand C. Cytokine, elastase and oxygen radical release by Fusobacterium nucleatum-activated leukocytes: a possible pathogenic factor in periodontitis. J Clin Periodontol 2000; 27(10):758-62.
31. Tsai CC, Chen HS, Chen SL, et al. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005; 40(5):378-84. (Pubitemid 41252864)
32. Lee Y-S, Bak EJ, Kim M, Park W, Seo JT, Yoo Y-J. Induction of IL-8 in periodontal ligament cells by H(2)O (2). J Microbiol 2008; 46(5):579-84.
33. Soory M. A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2008; 2:5-12.
34. D'Aiuto F, Sabbah W, Netuveli G, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008; 93(10):3989-94.
35. Del Turco S, Navarra T, Gastaldelli A, Basta G. Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach. Microvasc Res 2011; 82(1):73-6.
36. Andrassy M, Igwe J, Autschbach F, et al. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 2006; 169(4): 1223-37. (Pubitemid 351194359)
37. Holla LI, Kanková K, Fassmann A, et al. Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: a preliminary study. J Periodontol 2001; 72(12):1742-6. (Pubitemid 34092741)
38. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97(7):889-901. (Pubitemid 29375048)
39. Schmidt AM, Weidman E, Lalla E, et al. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996; 31(7):508-15. (Pubitemid 126463842)
40. Murillo J, Wang Y, Xu X, et al. Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior. J Periodontol 2008; 79(11):2190-9.
41. Ren L, Fu Y, Deng Y, Qi L, Jin L. Advanced glycation end products inhibit the expression of collagens type I and III by human gingival fibroblasts. J Periodontol 2009; 80(7):1166-73.
42. Steffensen B, Häkkinen L, Larjava H. Proteolytic events of wound-healing-coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 2001; 12(5):373-98. (Pubitemid 33022035)
43. Lackier KP, Cochran DL, Hoang AM, Takacs V, Oates TW. Development of an in vitro wound healing model for periodontal cells. J Periodontol 2000; 71(2):226-37.
44. Ohi T, Uehara Y, Takatsu M, Watanabe M, Ono T. Hypermethylation of CpGs in the promoter of the COL1A1 gene in the aged periodontal ligament. J Dent Res 2006; 85(3):245-50. (Pubitemid 43827733)
45. Martínez-Clemente M, Clària J, Titos E. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. Curr Opin Clin Nutr Metab Care 2011; 14(4):347-53.